The Japan News Astellas Collaborates with Vir to Develop Its Experimental Prostate Cancer Drug
Feb 23 (Reuters) - Japan's Astellas 4503.T and Vir Biotechnology VIR.O said on Monday they will together develop and commercialize the U.S. drug developer's prostate cancer experimental drug.